Federal contract award
75N91022F00007
THESE WILL BE USED TO ISOLATE AND SEQUENCE SINGLE CELLS FROM TUMORS AND METASTATIC SITES BY JAE YOUNG SO AND ABDUL AHAD
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | 75N98022A00032 |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $15.2K |
| Current contract value | $15.2K |
| Potential contract value / ceiling | $15.2K |
| Start date | Aug 28, 2022 |
| Current end date | Sep 27, 2022 |
| Potential end date | Sep 27, 2022 |
| Latest award activity | Aug 28, 2022 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 28, 2022 | 0 | $15.2K | THESE WILL BE USED TO ISOLATE AND SEQUENCE SINGLE CELLS FROM TUMORS AND METASTATIC SITES BY JAE YOUNG SO AND ABDUL AHAD |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.